Loading
Latest filing published 14 Aug 2026 for BioNexus Gene Lab Corp.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Jook Yuen Low is known so far (14 August 2026): a share grant, in BioNexus Gene Lab Corp. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration